entri
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
suscept
cell
mediat
bind
viral
spike
protein
receptor
molecul
angiotensinconvert
enzym
pseudotyp
system
vesicular
stomat
viru
vsv
particl
vsv
g
system
vsvg
gene
replac
green
fluoresc
protein
gfp
gene
report
produc
pseudotyp
vsv
incorpor
envelop
glycoprotein
rna
virus
system
use
studi
viral
envelop
glycoprotein
due
abil
grow
high
titer
varieti
cell
line
infect
target
cell
pseudotyp
vsv
detect
readili
gfpposit
cell
within
hour
postinfect
hpi
high
level
gfp
express
vsv
g
system
thu
pseudotyp
sarscov
protein
use
vsv
g
system
may
advantag
studi
function
sarscov
protein
well
develop
rapid
system
examin
neutral
antibodi
specif
sarscov
infect
report
describ
rapid
detect
system
sarscov
proteinbear
vsv
pseudotyp
infect
effect
peptid
sarscovsmedi
infect
investig
use
system
plasmid
cdna
fulllength
truncat
version
sarscov
protein
lack
ctermin
amino
acid
clone
mammalian
express
vector
yield
plasmid
pkssarss
respect
plasmid
carri
cdna
revers
orient
use
neg
control
experi
regard
pseudotyp
product
prepar
vsv
pseudotyp
h
transfect
cell
pkssarss
cell
infect
vsv
g
g
gene
replac
gfp
gene
h
cultur
supernat
collect
store
use
vero
cell
grown
glass
slide
inocul
pseudovirus
infect
pseudotyp
viru
detect
monitor
gfp
express
fluoresc
microscop
number
gfpexpress
cell
count
use
imagej
softwar
http
rsbinfonihgovij
inhibit
assay
vsv
pseudotyp
incub
serial
dilut
inhibitor
h
mixtur
inocul
onto
vero
cell
inhibitor
angiotensin
angiotensin
ii
desarg
bradykinin
purchas
sigma
inhibitor
purchas
phoenix
pharmaceut
gener
vsv
pseudotyp
fulllength
sarscov
protein
express
plasmid
pkssarss
transfect
cell
follow
infect
vsv
g
cultur
supernat
infect
cell
inocul
onto
vero
cell
cell
line
commonli
use
sarscov
propag
small
number
gfpexpress
cell
observ
data
shown
observ
indic
vsv
pseudotyp
bear
fulllength
sarscov
protein
highli
infecti
next
gener
vsv
pseudotyp
sarscov
protein
ctermin
amino
acid
truncat
use
plasmid
plasmid
use
neg
control
cell
transfect
either
infect
vsv
g
h
cultur
supernat
infect
cell
collect
inocul
onto
vero
cell
shown
figur
number
infecti
unit
iu
pseudotyp
vsv
ml
refer
obtain
cell
transfect
significantli
higher
neg
control
partial
delet
cytoplasm
domain
sarscov
protein
allow
effici
incorpor
vsv
particl
led
pseudotyp
gener
high
titer
intact
cytoplasm
domain
sarscov
protein
may
interrupt
proper
assembl
pseudotyp
particl
infect
retrovirusbas
pseudotyp
usual
measur
hpi
infect
vsvbase
pseudotyp
detect
h
interestingli
gfp
express
vero
cell
detect
clearli
h
inocul
time
cours
analysi
number
gfpposit
cell
indic
possibl
quantifi
infect
hpi
fig
therefor
subsequ
analys
count
number
gfpposit
cell
infect
hpi
preincub
angiotensin
angiotensin
ii
desarg
bradykinin
br
follow
inocul
onto
vero
cell
infect
pseudotyp
examin
use
method
describ
figur
infect
vero
cell
neutral
antisarscov
antibodi
data
shown
furthermor
recombin
human
ectodomain
protein
solubl
strongli
affect
infect
affect
infect
vsvgbear
pseudotyp
vsv
g
g
fig
result
indic
infect
mediat
sarscov
protein
manner
investig
whether
known
peptid
inhibitor
compet
pseudotyp
viru
infect
shown
figur
pretreat
vero
cell
shown
inhibit
enzymat
activ
inhibit
infect
pretreat
peptid
substrat
angiotensin
angiotensin
ii
desarg
bradykinin
higher
concentr
requir
inhibit
infect
indic
inhibit
weak
fig
enzymat
activ
requir
protein
act
sarscov
receptor
howev
result
indic
partial
influenc
function
sarscov
receptor
investig
includ
inhibit
studi
live
sarscov
necessari
elucid
efficaci
result
suggest
peptid
use
specif
inhibitor
sarscovsmedi
infect
base
result
neutral
experi
use
antisarscov
antibodi
solubl
conclud
infect
target
cell
mediat
sarscov
protein
assay
system
describ
use
develop
safe
rapid
method
detect
neutral
antibodi
sarscov
also
screen
inhibitor
sarscovsmedi
infect
work
support
part
grantinaid
ministri
health
labor
welfar
japan
japan
health
scienc
foundat
tokyo
japan
